M, B., & F, A. (2019). Dual GIP–GLP1-Receptor Agonists In The Treatment Of Type 2 Diabetes: A Short Review On Emerging Data And Therapeutic Potential. Dove Medical Press.
Cita Chicago Style (17a ed.)M, Bastin, y Andreelli F. Dual GIP–GLP1-Receptor Agonists In The Treatment Of Type 2 Diabetes: A Short Review On Emerging Data And Therapeutic Potential. Dove Medical Press, 2019.
Cita MLA (8a ed.)M, Bastin, y Andreelli F. Dual GIP–GLP1-Receptor Agonists In The Treatment Of Type 2 Diabetes: A Short Review On Emerging Data And Therapeutic Potential. Dove Medical Press, 2019.
Precaución: Estas citas no son 100% exactas.